These eight hub genes (ADAMTS9-AS1, DLX6-AS1, LINC00470, LINC00520, LINC01497, LINC01749, MAMDC2-AS1, and SSTR5-AS1) may offer novel therapeutic strategies for patients with ESCC. This evidence concerns the gene ADAMTS9 and esophageal squamous cell carcinoma.